Thus, the identification of KLF8 as a critical feed-forward inducer of CXCR4 expression and activation of FAK in breast cancer cells presents an excellent therapeutic target to correct aberrant signaling of both FAK and CXCR4 specifically in cancer cells. This evidence concerns the gene PTK2 and breast carcinoma.